BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 33915597)

  • 1. Biomarker evaluation under imperfect nested case-control design.
    Wang X; Zheng Y; Jensen MK; He Z; Cai T
    Stat Med; 2021 Aug; 40(18):4035-4052. PubMed ID: 33915597
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New weighting methods when cases are only a subset of events in a nested case-control study.
    Zhou QM; Wang X; Zheng Y; Cai T
    Biom J; 2022 Oct; 64(7):1240-1259. PubMed ID: 35754309
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluating longitudinal markers under two-phase study designs.
    Maziarz M; Cai T; Qi L; Lok AS; Zheng Y
    Biostatistics; 2019 Jul; 20(3):485-498. PubMed ID: 29912281
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resampling Procedures for Making Inference under Nested Case-control Studies.
    Cai T; Zheng Y
    J Am Stat Assoc; 2013 Jan; 108(504):1532-1544. PubMed ID: 24436503
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Robust risk prediction with biomarkers under two-phase stratified cohort design.
    Payne R; Yang M; Zheng Y; Jensen MK; Cai T
    Biometrics; 2016 Dec; 72(4):1037-1045. PubMed ID: 27037494
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estimation of the causal effects of time-varying treatments in nested case-control studies using marginal structural Cox models.
    Takeuchi Y; Hagiwawa Y; Komukai S; Matsuyama Y
    Biometrics; 2024 Jan; 80(1):. PubMed ID: 38465985
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluating prognostic accuracy of biomarkers in nested case-control studies.
    Cai T; Zheng Y
    Biostatistics; 2012 Jan; 13(1):89-100. PubMed ID: 21856652
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kernel machine testing for risk prediction with stratified case cohort studies.
    Payne R; Neykov M; Jensen MK; Cai T
    Biometrics; 2016 Jun; 72(2):372-81. PubMed ID: 26692376
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of biomarkers for risk prediction with nested case-control studies.
    Zhou QM; Zheng Y; Cai T
    Clin Trials; 2013 Oct; 10(5):677-9. PubMed ID: 24013405
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-parametric Evaluation of Biomarker Accuracy under Nested Case-control Studies.
    Cai T; Zheng Y
    J Am Stat Assoc; 2011 Jan; 106(494):569-580. PubMed ID: 22844169
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluating classification performance of biomarkers in two-phase case-control studies.
    Wang L; Huang Y
    Stat Med; 2019 Jan; 38(1):100-114. PubMed ID: 30209824
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessing incremental value of biomarkers with multi-phase nested case-control studies.
    Zhou QM; Zheng Y; Chibnik LB; Karlson EW; Cai T
    Biometrics; 2015 Dec; 71(4):1139-49. PubMed ID: 26195245
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Weighted metrics are required when evaluating the performance of prediction models in nested case-control studies.
    Rentroia-Pacheco B; Bellomo D; Lakeman IMM; Wakkee M; Hollestein LM; van Klaveren D
    BMC Med Res Methodol; 2024 May; 24(1):115. PubMed ID: 38760688
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluating and comparing biomarkers with respect to the area under the receiver operating characteristics curve in two-phase case-control studies.
    Huang Y
    Biostatistics; 2016 Jul; 17(3):499-522. PubMed ID: 26883772
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Semiparametric isotonic regression analysis for risk assessment under nested case-control and case-cohort designs.
    Li W; Li R; Feng Z; Ning J
    Stat Methods Med Res; 2020 Aug; 29(8):2328-2343. PubMed ID: 31868119
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estimation and inference for semi-competing risks based on data from a nested case-control study.
    Jazić I; Lee S; Haneuse S
    Stat Methods Med Res; 2020 Nov; 29(11):3326-3339. PubMed ID: 32552435
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nonparametric Maximum Likelihood Estimators of Time-Dependent Accuracy Measures for Survival Outcome Under Two-Stage Sampling Designs.
    Liu D; Cai T; Lok A; Zheng Y
    J Am Stat Assoc; 2018; 113(522):882-892. PubMed ID: 30555194
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Goodness-of-fit two-phase sampling designs for time-to-event outcomes: a simulation study based on New York University Women's Health Study for breast cancer.
    Lee M; Chen J; Zeleniuch-Jacquotte A; Liu M
    BMC Med Res Methodol; 2023 May; 23(1):119. PubMed ID: 37208600
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assess predictive values of a binary diagnostic test under a nested case-control design.
    Wu Y
    J Biopharm Stat; 2022 Mar; 32(2):219-229. PubMed ID: 34546838
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of two-phase sampling data with semiparametric additive hazards models.
    Sun Y; Qian X; Shou Q; Gilbert PB
    Lifetime Data Anal; 2017 Jul; 23(3):377-399. PubMed ID: 26995733
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.